Assessment and optimization of cell engraftment after transplantation into the heart.
about
Dendritic Polymers for TheranosticsMicrotissues in Cardiovascular Medicine: Regenerative Potential Based on a 3D MicroenvironmentCell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac RegenerationProgramming and reprogramming a human heart cellTranslating stem cell research to cardiac disease therapies: pitfalls and prospects for improvementConsiderations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytesTargeting survival pathways to create infarct-spanning bridges of human embryonic stem cell-derived cardiomyocytes.Endothelial progenitor cells (EPCs) as gene carrier system for rat model of human gliomaAllogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathyBioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipientsThe stuttering progress of cell therapy for heart diseaseCell Size Critically Determines Initial Retention of Bone Marrow Mononuclear Cells in the Heart after Intracoronary Injection: Evidence from a Rat ModelTracking of stem cells in vivo for cardiovascular applications.Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers.Secondary sphere formation enhances the functionality of cardiac progenitor cells.Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair.Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury.Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo.A multistep procedure to prepare pre-vascularized cardiac tissue constructs using adult stem sells, dynamic cell cultures, and porous scaffolds.Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction.Intramyocardial cell delivery: observations in murine heartsThe modulation of cardiac progenitor cell function by hydrogel-dependent Notch1 activation.Intracoronary delivery of bone-marrow-derived stem cells.Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusionCardiac cell therapy: where we've been, where we are, and where we should be headed.Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathwayNovel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation.Coronary artery ligation and intramyocardial injection in a murine model of infarction.Intra-articular transplantation of atsttrin-transduced mesenchymal stem cells ameliorate osteoarthritis development.Extracellular Matrix can Recover the Downregulation of Adhesion Molecules after Cell Detachment and Enhance Endothelial Cell Engraftment.Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular diseaseConcomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial InfarctionMembrane estrogen receptor alpha is an important modulator of bone marrow C-Kit+ cells mediated cardiac repair after myocardial infarction.Transplantation Effectiveness of Induced Pluripotent Stem Cells Is Improved by a Fibrinogen Biomatrix in an Experimental Model of Ischemic Heart FailureCell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies.Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective.Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction.Bioengineering heart muscle: a paradigm for regenerative medicineFibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles.
P2860
Q26746182-BA795B9E-52E2-49D4-A414-4BD74B77502DQ26748747-43E18836-9115-4CE7-981C-63245D3952F5Q26765916-A7DCE948-4648-426F-825E-63B8C9F9C4C0Q26823933-4D2B12EF-E444-427C-AE2D-0A0AE1565F80Q26860340-96DE097C-1BD6-41F5-A3EC-56136A212719Q26865173-ABB9B093-2CB5-47E9-97D2-78D6C9560EAFQ27308987-83B6DB9B-CBF9-48FC-830B-90FA6477B5DCQ27309949-CF7C3915-2CF9-4D2B-B819-0ED6EFF44653Q27322954-A450B8C8-FC7B-4CDB-BD96-16ADAB3B77F8Q27347592-BB40790E-E7C0-40CD-A55D-817D43FE116AQ28247457-B458DED0-D7F3-464A-A398-FB416D775B1DQ28552343-C6282E04-D443-4567-98DD-8925AB02B068Q30443013-BC2AF7F5-0E89-43EF-881D-8180065D1D37Q30473970-739C2150-1635-4A45-BA54-BDDA7935BBCFQ30524835-84EB5B10-95F1-4D22-8DAA-8266F1113934Q30601810-81FB86C7-F245-4332-B19E-29C4E85CFBBBQ30841694-80AB48AE-8BCE-4473-A04E-CF6B86F9651BQ33690013-8AFFA979-E452-44C0-961D-F1B34B7AE02BQ33701439-3A30986D-62DD-4C8C-BCCD-033891E0383CQ33746096-F590BE6F-1A64-403A-BDFE-55A017D7EEF1Q33873675-B99FC899-275E-4D7E-AE82-CFB990DC49B1Q34115085-0DE0E1A4-5532-40D5-B336-C6BE171BBE7DQ34318046-D0EE130C-EF8A-4AFF-A151-DA1344C83044Q35068527-9039B9AA-B15B-479E-858D-A39A04BDFE1AQ35144550-CD812F51-8E6D-4544-93A2-EA15A1CA06A0Q35163294-17E8A468-38C1-44BB-823B-6DB046F0B6D4Q35234806-D23C17A7-2E55-4F41-A780-93DEB99D4BC4Q35391492-2691F719-7D21-4C20-9D63-6865A71659D2Q35552093-4483F1C9-6B3D-40AC-B9FB-FE8297A1BD2CQ35679153-F56B3BC7-2AE4-4447-9925-790341BC2207Q35777287-9FFF8FB5-45AD-4177-9A04-F5E0F20F5497Q35804026-1A85EED2-353E-4BAE-9D43-AB4396392137Q35824554-25EFA3DA-B830-458C-BFC4-5A8B27E5FB9FQ35853824-E7DCAC07-83EC-44F3-9C05-4FB72092BD19Q35865904-4391A344-8B3E-451E-B5F5-935713BFAD92Q35942474-4A89A5AC-705F-4021-87F3-8F33A5A72B0BQ35944159-8FB5C284-EB24-44F5-A3A7-360BF733A421Q36085396-40718C2B-43D7-4A60-9F86-FBAA19B2AC4EQ36117532-E814649C-C7BD-4391-B759-F2CF38F3C2E9Q36121826-6115E272-ED9A-4A34-972D-848A882CCD47
P2860
Assessment and optimization of cell engraftment after transplantation into the heart.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Assessment and optimization of cell engraftment after transplantation into the heart.
@ast
Assessment and optimization of cell engraftment after transplantation into the heart.
@en
type
label
Assessment and optimization of cell engraftment after transplantation into the heart.
@ast
Assessment and optimization of cell engraftment after transplantation into the heart.
@en
prefLabel
Assessment and optimization of cell engraftment after transplantation into the heart.
@ast
Assessment and optimization of cell engraftment after transplantation into the heart.
@en
P2093
P2860
P1433
P1476
Assessment and optimization of cell engraftment after transplantation into the heart.
@en
P2093
Eduardo Marbán
John V Terrovitis
Rachel Ruckdeschel Smith
P2860
P304
P356
10.1161/CIRCRESAHA.109.208991
P577
2010-02-01T00:00:00Z